NeuroMetrix Past Earnings Performance
Past criteria checks 0/6
NeuroMetrix's earnings have been declining at an average annual rate of -21.9%, while the Medical Equipment industry saw earnings growing at 4.3% annually. Revenues have been declining at an average rate of 16% per year.
Key information
-21.9%
Earnings growth rate
25.7%
EPS growth rate
Medical Equipment Industry Growth | 4.3% |
Revenue growth rate | -16.0% |
Return on equity | -28.0% |
Net Margin | -86.6% |
Next Earnings Update | 22 Feb 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How NeuroMetrix makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 23 | 6 | -6 | 8 | 2 |
30 Jun 23 | 7 | -5 | 8 | 3 |
31 Mar 23 | 8 | -5 | 8 | 3 |
31 Dec 22 | 8 | -4 | 7 | 3 |
30 Sep 22 | 8 | -5 | 7 | 3 |
30 Jun 22 | 8 | -4 | 7 | 3 |
31 Mar 22 | 8 | -3 | 6 | 3 |
31 Dec 21 | 8 | -2 | 6 | 2 |
30 Sep 21 | 8 | -2 | 6 | 1 |
30 Jun 21 | 8 | -1 | 6 | 1 |
31 Mar 21 | 7 | -1 | 5 | 1 |
31 Dec 20 | 7 | -2 | 6 | 2 |
30 Sep 20 | 7 | -3 | 6 | 2 |
30 Jun 20 | 7 | -4 | 7 | 1 |
31 Mar 20 | 8 | -6 | 9 | 2 |
31 Dec 19 | 9 | -4 | 11 | 2 |
30 Sep 19 | 11 | -6 | 13 | 3 |
30 Jun 19 | 13 | -3 | 14 | 4 |
31 Mar 19 | 14 | 1 | 15 | 4 |
31 Dec 18 | 16 | 0 | 15 | 5 |
30 Sep 18 | 17 | 0 | 16 | 4 |
30 Jun 18 | 17 | -7 | 17 | 4 |
31 Mar 18 | 18 | -11 | 17 | 3 |
31 Dec 17 | 17 | -20 | 17 | 3 |
30 Sep 17 | 16 | -20 | 17 | 3 |
30 Jun 17 | 16 | -17 | 17 | 3 |
31 Mar 17 | 14 | -38 | 16 | 4 |
31 Dec 16 | 12 | -35 | 16 | 4 |
30 Sep 16 | 11 | -43 | 16 | 4 |
30 Jun 16 | 10 | -42 | 15 | 4 |
31 Mar 16 | 8 | -23 | 14 | 3 |
31 Dec 15 | 7 | -21 | 13 | 3 |
30 Sep 15 | 6 | -13 | 12 | 3 |
30 Jun 15 | 5 | -11 | 11 | 3 |
31 Mar 15 | 5 | -12 | 10 | 3 |
31 Dec 14 | 6 | -11 | 8 | 3 |
30 Sep 14 | 6 | -12 | 7 | 3 |
30 Jun 14 | 5 | -11 | 7 | 3 |
31 Mar 14 | 5 | -8 | 7 | 2 |
31 Dec 13 | 5 | -9 | 8 | 3 |
30 Sep 13 | 5 | -7 | 8 | 3 |
30 Jun 13 | 6 | -9 | 9 | 4 |
31 Mar 13 | 7 | -10 | 10 | 4 |
Quality Earnings: NLZ0 is currently unprofitable.
Growing Profit Margin: NLZ0 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NLZ0 is unprofitable, and losses have increased over the past 5 years at a rate of 21.9% per year.
Accelerating Growth: Unable to compare NLZ0's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NLZ0 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).
Return on Equity
High ROE: NLZ0 has a negative Return on Equity (-27.99%), as it is currently unprofitable.